Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

HIV Infection

Free Subscription 30.03.2026 17 AIDS 1 Antimicrob Agents Chemother 1 BMC Neurol 5 Clin Infect Dis 2 HIV Med 3 J Acquir Immune Defic Syndr 2 J Med Virol 1 Lancet 1 Neurology 1 PLoS Comput Biol 1 PLoS Med 8 PLoS One 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. BAILIN SS, Gabriel CL, Gangula RD, Hannah L, et al
   Adipose tissue microvascular is linked to insulin resistance and lipidome alterations in treated HIV.
   AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004491.
   PubMed         Abstract available
   
   
2. KWOK M, Dandapani H, Ibrahim N, Bloomfield GS, et al
   Estimating the degree of cardiovascular disease risk under-prediction in people living with HIV by existing risk models: an updated meta-analysis.
   AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004492.
   PubMed         Abstract available
   
   
3. PENNETZDORFER N, Naik V, Montezuma-Rusca JM, Sklar P, et al
   Baseline and week 48 resistance analysis in participants receiving bictegravir + lenacapavir in the phase 2 ARTISTRY-1 study.
   AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004495.
   PubMed         Abstract available
   
   
4. CHEN T, Chen X, Wang S, Wang L, et al
   Male-specific association of HIV infection with lower risk of hyperuricemia is mediated by lower BMI and AGR.
   AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004490.
   PubMed         Abstract available
   
   
5. AUNG HL, Patel P, Gray RT, Asselin J, et al
   Sustained viral suppression among people living with HIV in the era of Undetectable = Untransmittable (U = U) in Australia.
   AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004488.
   PubMed         Abstract available
   
   
6. GUILAMO-RAMOS V, Thimm-Kaiser M, Benzekri A, Stafford SR, et al
   The price of invisibility: a cascading disaster in the US Latino HIV epidemic.
   AIDS. 2026 Mar 26. doi: 10.1097/QAD.0000000000004493.
   PubMed        
   
   
7. MCFARLANE WJ, Brogly SB, Flemming JA, Martinez-Cajas J, et al
   HIV-sex interaction effect on risk of hepatitis C-related cirrhosis, decompensation, and hepatocellular carcinoma.
   AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004501.
   PubMed         Abstract available
   
   
8. METE ATASEVER N, Dede E, Yilmaz S, Akkoc G, et al
   Meningococcal and pneumococcal carriage in children living with HIV: a multi-center prospective study from Turkiye (MENPHIV-TR study).
   AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004500.
   PubMed         Abstract available
   
   
9. CHALOUNI M, Torgersen J, Rentsch CT, Van Santen DK, et al
   Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for Hepatitis C virus in people with HIV.
   AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004499.
   PubMed         Abstract available
   
   
10. HWANG YJ, Lesko CR, Brown TT, Alexander GC, et al
    Changes in weight and glycemia after initiation of integrase strand transfer inhibitors among people with HIV and diabetes in the United States and Canada.
    AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004502.
    PubMed         Abstract available
    
    
11. AIZIRE KJ, Lewis L, Pettifor JM, Atuhaire P, et al
    Bone turnover marker trajectories in postpartum women living with HIV compared to women without HIV.
    AIDS. 2026 Mar 26. doi: 10.1097/QAD.0000000000004489.
    PubMed         Abstract available
    
    
12. LAHIRI CD, Soibi-Harry AP, Musonge-Effoe J, Alvarez JA, et al
    Association between plasma concentrations of integrase strand transfer inhibitors and body weight gain in women living with HIV.
    AIDS. 2026 Mar 26. doi: 10.1097/QAD.0000000000004496.
    PubMed         Abstract available
    
    
13. CROMHOUT GZ, Bengu N, Herbert NG, Fillis R, et al
    Increases in total HIV-1 nucleic acid in whole blood precede plasma rna rebound during paediatric analytical treatment interruption.
    AIDS. 2026 Mar 26. doi: 10.1097/QAD.0000000000004506.
    PubMed         Abstract available
    
    
14. KEKITIINWA AR, Juma M, Tumusiime C, Ssebunya RN, et al
    Integrating tuberculosis services with the Orphans and Vulnerable Children Program in Rwenzori region, Uganda, 2022-2023.
    AIDS. 2026 Mar 26. doi: 10.1097/QAD.0000000000004503.
    PubMed         Abstract available
    
    
15. BONO V, Tincati C, Augello M, Rovito R, et al
    Age and viral replication, not vertical HIV acquisition, drive inflammation and T-cell dysfunction in heavily treatment experienced: data from the Prestigio Registry.
    AIDS. 2026;40:690-693.
    PubMed         Abstract available
    
    
16. RUBIN LH, Maki PM, Du Y, Dastgheyb RM, et al
    Stability of the translocator protein 18 kDa density within cognitive circuits in brains of virally-suppressed people with HIV.
    AIDS. 2026;40:693-696.
    PubMed         Abstract available
    
    
17. SAWATZKY J, Conroy AL, Brochon J, Kakkar F, et al
    Dysregulation of circulating angiopoietins is associated with low birth weight in children who are HIV-exposed and uninfected.
    AIDS. 2026;40:696-699.
    PubMed         Abstract available
    
    

    
    Antimicrob Agents Chemother

18. NEVERETTE NC, Winfield J, Chaparro-Caceres N, Ho KS, et al
    Contemporary antiretroviral pharmacology in the male genital tract: implications for HIV treatment and prevention.
    Antimicrob Agents Chemother. 2026 Mar 23:e0140125. doi: 10.1128/aac.01401.
    PubMed         Abstract available
    
    

    
    BMC Neurol

19. GOUSE H, Nhlabatsi-Khumalo Z, Chernotsky R, Twamley EW, et al
    Changes in cognitive performance following combined CogSMART-SA and BrainHQ interventions: a pilot study.
    BMC Neurol. 2026 Mar 21. doi: 10.1186/s12883-026-04778.
    PubMed        
    
    

    
    Clin Infect Dis

20. LINAS BP
    Centering AIDS Drug Assistance Programs in the US HIV Response.
    Clin Infect Dis. 2026 Mar 25:ciag035. doi: 10.1093.
    PubMed        
    
    
21. MCMANUS KA, Killelea A, Rogers EQ, Liu F, et al
    State AIDS Drug Assistance Programs' Contribution to the US Viral Suppression, 2015-2022.
    Clin Infect Dis. 2026 Mar 25:ciag034. doi: 10.1093.
    PubMed         Abstract available
    
    
22. MENZA TW, Berzkalns A, Cannon CA, Balkus J, et al
    The population-level impact of doxycycline post-exposure prophylaxis on syphilis in King County, WA: an interrupted time series analysis.
    Clin Infect Dis. 2026 Mar 26:ciag209. doi: 10.1093.
    PubMed         Abstract available
    
    
23. GRABER CJ, Landovitz RJ, Branch-Elliman W
    Providing the Best Infectious Diseases and Primary Care to Our Patients With HIV: Time for Delivery Models to Evolve.
    Clin Infect Dis. 2026 Mar 27:ciag096. doi: 10.1093.
    PubMed         Abstract available
    
    
24. CHIDA N
    Staying in the Tent: Why Infectious Disease Physicians Remain Essential to Human Immunodeficiency Virus Primary Care.
    Clin Infect Dis. 2026 Mar 27:ciag097. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

25. ARCOS-RUEDA MDM, De Miguel-Buckley R, De Gea Grela A, Busca C, et al
    Hepatitis B reactivation in people living with HIV and isolated anti-HBc receiving tenofovir-sparing dual antiretroviral therapy.
    HIV Med. 2026 Mar 25. doi: 10.1111/hiv.70231.
    PubMed         Abstract available
    
    
26. CODONAL A, Lazaro A, Martinez E, Delgado A, et al
    Use of long-acting cabotegravir and rilpivirine in people living with HIV: A prospective observational cohort study.
    HIV Med. 2026 Mar 26. doi: 10.1111/hiv.70230.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

27. KALICHMAN SC
    Response to Mahida and Jagtap's Comment on "Dose Determination Trial for Evidence-Based Behavioral Counseling to Improve HIV Care Engagement and Treatment Adherence".
    J Acquir Immune Defic Syndr. 2026 Mar 24. doi: 10.1097/QAI.0000000000003872.
    PubMed        
    
    
28. BODLEY N, Govender K, Moodley P, Samsunder N, et al
    Association between pharmacological tenofovir adherence measures and subsequent 24-week viral load outcomes for people with HIV in South Africa.
    J Acquir Immune Defic Syndr. 2026 Mar 26. doi: 10.1097/QAI.0000000000003866.
    PubMed         Abstract available
    
    
29. VANDERVEEN LA, Selzer L, Chang S, Li J, et al
    Resistance Analysis of Weekly Islatravir Plus Lenacapavir in People with HIV at 48 Weeks.
    J Acquir Immune Defic Syndr. 2026 Mar 26. doi: 10.1097/QAI.0000000000003873.
    PubMed         Abstract available
    
    

    
    J Med Virol

30. LAEREMANS T, den Roover S, Nezic SJ, Allard SD, et al
    Proteasome Inhibition Reactivates Latent HIV-1 and Boosts NK Cell Killing via HLA-E Downregulation.
    J Med Virol. 2026;98:e70895.
    PubMed         Abstract available
    
    
31. PITA-MARTINEZ C, Munoz-Garcia P, Martinez I, Rava M, et al
    Elevated Zonulin-1 is Associated With an Increased Risk of Non-AIDS-Defining Cancers in People With HIV With Suboptimal Immune Recovery: A Case-Cohort Study.
    J Med Virol. 2026;98:e70884.
    PubMed         Abstract available
    
    

    
    Lancet

32. PAN D, Choi JS, Choi MJ, Phillips R, et al
    Respiratory virus research needs its own PPIE.
    Lancet. 2026;407:1144-1145.
    PubMed        
    
    

    
    Neurology

33. GOSSET A, Perez S, Thakral A, Nguyen T, et al
    Clinical Reasoning: A 67-Year-Old Man With Exercise Intolerance and Progressive Weakness.
    Neurology. 2026;106:e214830.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

34. SHIMAGAKI KS, Kher G, Lynch RM, Barton JP, et al
    Predicting viral sensitivity to antibodies using genetic sequences and antibody similarities.
    PLoS Comput Biol. 2026;22:e1014095.
    PubMed         Abstract available
    
    

    
    PLoS Med

35. AKULLIAN A, Ssempijja V, Breidenbecker D, Nalugoda F, et al
    Evaluating the biomedical and behavioral drivers of HIV incidence decline in adolescent girls and young women in Uganda: A mathematical modeling study.
    PLoS Med. 2026;23:e1004993.
    PubMed         Abstract available
    
    

    
    PLoS One

36. BAEK YJ, Kim S, Lee E, Park B, et al
    Characteristics and geographical distribution of syphilis among people with human immunodeficiency virus and the National Population in Republic of Korea.
    PLoS One. 2026;21:e0340324.
    PubMed         Abstract available
    
    
37. LUPONE T, Brantly A, Oteju O, Matt SM, et al
    High-throughput high content quantification of HIV-1 viral infectious output.
    PLoS One. 2026;21:e0328121.
    PubMed         Abstract available
    
    
38. JEYAM A, Schmidt E, Bechange S, Pye S, et al
    Factor structure and psychometric properties of an adapted HIV stigma tool for measuring disability-related stigma among smallholder farmers in Western Kenya - Findings from a cross-sectional study.
    PLoS One. 2026;21:e0345597.
    PubMed         Abstract available
    
    
39. SUMBA S, Kailembo A, Ismail A, Njau P, et al
    Prevalence and correlates of low-level viremia and viral load non-suppression among adults on HIV treatment: Results from the Tanzania HIV Impact Survey, 2022-2023.
    PLoS One. 2026;21:e0344439.
    PubMed         Abstract available
    
    
40. NUWAHEREZA D, Nabisere A, Namatovu I, Ngabirano TD, et al
    Crests, troughs, and plateaus: Using story theory to explore the experiences of adolescents and young people living with HIV in Kampala, Uganda.
    PLoS One. 2026;21:e0345499.
    PubMed         Abstract available
    
    
41. KHAN AA, Salama EA, Seleem MN
    Synergistic antifungal activity of antiretrovirals with amphotericin B against Aspergillus species.
    PLoS One. 2026;21:e0344286.
    PubMed         Abstract available
    
    
42. NYAMASVE JG, Pindiriri C, Mapako T, Ingwani A, et al
    Provider costs of Antiretroviral therapy (ART) in Zimbabwe: The value of using time-driven activity based costing methods in a low resource setting.
    PLoS One. 2026;21:e0345316.
    PubMed         Abstract available
    
    
43. BOONSAEN T, Ratanasuwan W, Tassaneetrithep B, Thientunyakit T, et al
    Correction: Progression of carotid intima-media thickness, visceral fat accumulation and metabolic derangement in people living with HIV initiating antiretroviral therapy: A prospective cohort study at Thailand's tertiary care center.
    PLoS One. 2026;21:e0345774.
    PubMed         Abstract available
    
    

    
    Vaccine

44. DE ROSA SC, Gravett RM, Hahn WO, Villaran M, et al
    DNA electroporation of HIV Env elicits robust T cell responses and memory B cell responses with muted serum antibody levels that can be boosted with recombinant protein.
    Vaccine. 2026;79:128487.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum